Newsroom

Sorted by: Latest

-

LEO Pharma Presents New 12-Month Real-World Data for Tralokinumab at AAD 2026

MADISON, N.J.--(BUSINESS WIRE)--LEO Pharma A/S, a global leader in medical dermatology, today announced the presentation of new post-hoc analyses of 12‑month real‑world data from the TRACE study of tralokinumab, at the 2026 American Academy of Dermatology (AAD) Annual Meeting. TRACE is a prospective, non-interventional, international study evaluating adult patients receiving tralokinumab, with analyses assessing minimal disease activity and outcomes in patient subgroups, including those with H&...
-

Nine Lyons & Simmons Attorneys Named to 2026 Texas Super Lawyers and Rising Stars Lists

DALLAS--(BUSINESS WIRE)--Lyons & Simmons, LLP, is proud to announce that all nine of its attorneys have been named to the 2026 Texas Super Lawyers and Rising Stars lists, a significant increase from six firm honorees the year before. The firm’s 2026 Texas Super Lawyers honorees are Michael Lyons, Chris Simmons, Chris Carr, Wes Black, and Stephen Higdon. This marks the first Super Lawyers selection for Mr. Higdon after eight consecutive years being recognized on the companion Rising Stars li...
-

Eurofins Scientific SE: Weekly Report on Share Repurchases from 23th March to 27th March 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 23/03/2026 FR0014000MR3 48 000 61.1218 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 23/03/2026 FR0014000MR3 12 000 61.2959 CEUX EUROFINS SCIENTIFIC 529900JEHFM...
-

Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Demonstrated Significantly Greater LDL-C Reductions at Eight Weeks Compared to Guideline-Recommended Oral Non-Statin Therapies When Added to Background Statins

RAHWAY, N.J.--(BUSINESS WIRE)--Enlicitide, an Investigational Oral PCSK9 Inhibitor, Demonstrated Significantly Greater LDL-C Reductions Compared to Oral Non-Statin Therapies...
-

Xtrackers (IE) plc UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Xtrackers (IE) plc Investment Company with Variable Capital Registered Office: 78 Sir John Rogerson's Quay, Dublin 2, Ireland Registration number: 393802 (the “Company”) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Dublin, 27 March 2026 This announcement is to inform the shareholders of the sub-funds listed in the table below (each a Sub-Fund, and together the Sub-Funds) (the Shareholders) on behalf of the board of directors of the Compa...
-

Harvest ETFs Announces Final March 2026 Cash Distribution for the Harvest Canadian T-Bill ETF

OAKVILLE, Ontario--(BUSINESS WIRE)--Harvest Portfolios Group Inc. (“Harvest”) announces the final March 2026 cash distribution for the following distribution for the Harvest Canadian T-Bill ETF for the month ending March 31, 2026. The distribution will be paid on or about April 6, 2026 to unitholders of record on March 31, 2026. Details regarding the final per unit cash distribution amount is as follows: Harvest ETF TSX Ticker Cash Distribution Harvest Canadian T-Bill ETF TBIL $0.0873 per unit...
-

FNB Harvest annonce à distribution en espèces finale de mars 2026 pour le FNB Harvest de bons du Trésor du Canada

OAKVILLE, Ontario--(BUSINESS WIRE)--Groupe de portefeuilles Harvest Inc. (« Harvest ») annonce la distribution en espèces finale de mars 2026 pour la distribution suivante pour le FNB Harvest de bons du Trésor du Canada pour le mois se terminant le 31 mars 2026. La distribution sera versée vers le 6 avril 2026 aux porteurs de parts inscrits le 31 mars 2026. Les détails concernant le montant final de la distribution en espèces par part sont les suivants : FNB Harvest Symbole TSX Distribution est...
-

AIHA Appoints Olena Bulgakova to Executive Director of AIHA Laboratory Accreditation Programs, LLC

FALLS CHURCH, Va.--(BUSINESS WIRE)--The American Industrial Hygiene Association (AIHA) has announced Olena Bulgakova as the new Executive Director of AIHA Laboratory Accreditation Programs, LLC (LAP). In this new capacity, Bulgakova is responsible for overseeing all AIHA LAP conformity assessment programs. Before her promotion to Executive Director, Bulgakova served as Senior Manager and then Director of LAP from 2019-2026. Over the past seven years at LAP Bulgakova managed operations, accredit...
-

Resecurity Supported Phoenix Challenge® 2026 – Information Operations (IO) Excellence in Cyberspace

LOS ANGELES--(BUSINESS WIRE)--Resecurity, a global cybersecurity and threat-intelligence company trusted by Fortune 100 enterprises and government agencies, was honored to participate in Phoenix Challenge 2026, held March 23–25, 2026, at the Crystal Gateway Marriott in Arlington, Virginia. Phoenix Challenge® is a U.S. Department of War conference focused on promoting innovation and advancing information operations (IO). The conference is presented under the oversight of the Office of Informatio...
-

Xtrackers II UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Xtrackers II Investment company with variable capital (Société d'investissement à capital variable) Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg R.C.S. Luxembourg B-124.284 (the “Company”) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Luxembourg, 27 March 2026 The board of directors of the Company (the “Board of Directors”) hereby informs all shareholders of the sub-funds listed in the table below (each a “Sub-Fund”, and...